GlassScriptPhysician profile
Kendra Maag
NPI 1275917932
$2,237.16
in general payments reported to CMS, 2019-2025
12 companies · $1,038 in 2025
The $1,038 reported for 2025 was more than what 87% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $156 · 2022: $318 · 2023: $454 · 2024: $272 · 2025: $1,038.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,764.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,763.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgenex LLC | $745.72 | 2025 | Renograft, Surgraft, Ardeograft |
| Tactile Systems Technology INC | $702.18 | 2021-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Cashflow Solutions, LLC | $217.46 | 2023-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Boston Scientific Corporation | $147.56 | 2021-2025 | Varithena Administration Pack |
| Novo Nordisk INC | $123.09 | 2023-2025 | Wegovy |
| Philips North America LLC | $89.38 | 2023 | |
| Abbvie INC. | $54.84 | 2024 | |
| Mimedx Group, INC. | $54.29 | 2024-2025 | |
| Revance Therapeutics, INC. | $45.43 | 2024 | Daxxify |
| Bsn Medical INC | $23.24 | 2022 | |
| Lilly USA, LLC | $17.15 | 2025 | Zepbound |
| Angiodynamics, INC. | $16.82 | 2024 | Venacure 1470 Pro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kendra Maag listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.